Dynamic regulation of endolysosomal programs drives melanoma progression

    Cancer Discovery
    |September 4, 2014
    PubMed

    Insights

    The small GTPase RAB7 drives melanoma development and is controlled by MYC and SOX10. This finding reveals new therapeutic targets for melanoma, a specific type of skin cancer.

    Area of Science:

    • Oncology
    • Molecular Biology
    • Genetics

    Background:

    • Melanoma is a significant skin cancer subtype.
    • The small GTPase RAB7 is implicated in cancer progression.
    • MYC and SOX10 are known oncogenes and transcription factors involved in development and cancer.

    Purpose of the Study:

    • To investigate the role of small GTPase RAB7 in melanoma.
    • To identify regulatory mechanisms controlling RAB7 in melanoma.
    • To explore potential therapeutic targets in melanoma.

    Main Methods:

    • Utilized molecular biology techniques.
    • Analyzed gene expression and protein levels.
    • Investigated regulatory pathways involving MYC and SOX10.

    Main Results:

    • Identified small GTPase RAB7 as a lineage-specific driver of melanoma.
    • Demonstrated that MYC and SOX10 regulate RAB7 activity.
    • Established a regulatory link between these key factors in melanoma.

    Conclusions:

    • Small GTPase RAB7 is a critical factor in melanoma pathogenesis.
    • MYC and SOX10 are key regulators of RAB7 in melanoma.
    • Targeting RAB7, MYC, or SOX10 may offer new therapeutic strategies for melanoma.

    Related Concept Videos

    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...
    3.6K
    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    1.5K
    Receptor Downregulation in MVBs01:15

    Receptor Downregulation in MVBs

    Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
    The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
    2.0K
    Delivery Pathways to the Lysosome01:36

    Delivery Pathways to the Lysosome

    Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
    Endocytosis
    In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
    7.6K
    The Intrinsic Apoptotic Pathway01:31

    The Intrinsic Apoptotic Pathway

    Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
    6.1K
    Interactions Between Signaling Pathways01:19

    Interactions Between Signaling Pathways

    Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
    Convergence and divergence, and cross-talk between signaling pathways
    Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
    4.6K